Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
McKesson
Moodys
Johnson and Johnson
Harvard Business School

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) and what is the scope of freedom to operate?

Trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) is the generic ingredient in nine branded drugs marketed by Lannett, Lilly, Forest Pharms, Wyeth Ayerst, Bristol Myers Squibb, Alpharma Us Pharms, Lederle, Impax Labs, Purepac Pharm, and Pal Pak, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

Summary for trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)
US Patents:0
Tradenames:9
Applicants:10
NDAs:11
DailyMed Link:trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) at DailyMed

US Patents and Regulatory Information for trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle TRIPLE SULFAS trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) SUSPENSION;ORAL 006920-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb TERFONYL trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) SUSPENSION;ORAL 006904-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb TERFONYL trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) TABLET;ORAL 006904-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Purepac Pharm TRIPLE SULFA trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) TABLET;ORAL 080086-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pal Pak TRIPLE SULFOID trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) TABLET;ORAL 080094-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Alpharma Us Pharms TRIPLE SULFA trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) SUSPENSION;ORAL 080280-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Mallinckrodt
Baxter
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.